SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,529.07 -242.65
( -0.33%)

Global Indices

Nasdaq

51,510.98 -338.64
(-0.65%)

Dow Jones

7,705.40 -59.01
(-0.76%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

24.1923243

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

304.37

EPS(TTM)

Face Value()

Div & Yield %

Back

Finkurve Financial Services standalone net profit rises 65.82% in the June 2026 quarter

Aug 13,2026

Net profit of Finkurve Financial Services rose 65.82% to Rs 8.44 crore in the quarter ended June 2026 as against Rs 5.09 crore during the previous quarter ended June 2025. Sales rose 88.31% to Rs 75.10 crore in the quarter ended June 2026 as against Rs 39.88 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	75.10	39.88	88
OPM %	51.05	36.36	-
PBDT	12.34	7.58	63
PBT	11.21	6.83	64
NP	8.44	5.09	66

72,529.07 -242.65 ( -0.33%)

51,510.98 -338.64 (-0.65%)

7,705.40 -59.01 (-0.76%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)